Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119692) titled 'Observation of the Anesthetic Effects of Anrikefon or Sufentanil Combined with Propofol in Hysteroscopic Surgery: A Prospective, Single-Center, Blinded, Randomized Controlled Trial' on March 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Yunnan Province
Condition:
Hysteroscopic surgery pain
Intervention:
The Anrelifin combined with propofol group (Group A):Anrekefen (ED95 dose determined by pre-experiment, intravenous push over 2 minutes) + Propofol (intravenous push at 2mg/kg, followed by TCI maintenance target concentration of 4µg/mL)
Rec...